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The US Centers for Disease Control and Prevention lists Brucella as a potential bioterrorism
threat requiring enhanced diagnostic capacity and surveillance (http://emergency.cdc.gov/
bioterrorism/). Successful treatment and management of patients after exposure to biological
threat agents depends on accurate and timely diagnosis, but many biothreat agents present with
similar, vague clinical signs – commonly referred to as ‘flu-like illness’. Diagnosis of brucellosis is
notoriously challenging, especially early in infection, and definitive diagnosis may require invasive
methods, e.g. bone marrow biopsy. We studied the pathogenesis of Brucella suis aerosol
infection in rhesus macaques in an effort to guide the diagnostic algorithm in case of possible
intentional exposure of humans. Rhesus proved to be an excellent model for human brucellosis;
the data showed that PCR DNA amplification testing of non-invasive diagnostic samples has the
potential to definitively detect a point-source outbreak immediately and for several days after
exposure.
INTRODUCTION
Naturally acquired human brucellosis remains common
worldwide. However, the incidence in the United States
and much of Europe is now very low, so brucellosis
probably would not be suspected as the cause of a febrile
illness in a US or European citizen with no travel history
(Young, 1995). Additionally, definitive diagnosis of
brucellosis has historically proven to be time-consuming
and uncertain. Blood culture may be unrewarding, as
viable bacteria are often undetectable in blood, and even
when present, growth is slow, with blood cultures requiring
up to 3 weeks of incubation before Brucella is detectable
(Yagupsky et al., 1997). Cultures on solid medium must be
maintained for 3 or more days before growth is detected
(Franco et al., 2007). These factors may combine to reduce
the probability of timely diagnosis of a point-source
outbreak. When detected in the acute stage, brucellosis is
much more treatable. Therefore, rapid, non-invasive
diagnostic methods can be of great benefit to provide
optimal opportunity for appropriate treatment and to
facilitate rapid investigation in case of intentional exposure
(Franz et al., 2001).
PCR assays have been designed that are specific for the
Brucella genus. Speciation by PCR is possible, but it is not
essential for initial diagnostics, especially for outbreak
detection. We chose to model B. suis for a variety of reasons
that are discussed later. Naturally acquired brucellosis
usually involves a low-exposure dose. In such cases, disease
progression is very slow, and an association with a point
source of exposure would not be expected. We did not
attempt to model natural brucellosis, but instead endea-
voured to model high-dose, aerosol exposure such as might
occur in a bioterrorism incident. Clearly, in such a case,
there would be a continuum of actual inhaled dose. We
focused on the high end of this spectrum, i.e. those that
wouldbeexpectedtopresentwithclinicalsignssoonenough
for a group of illnesses to be considered a single incident.
METHODS
Brucella strain and culture. Brucella suis 1330 was cultured on
tryptose blood agar base slant tubes for 48 h. The slant tube was
washed with 1 ml Brucella broth and the wash was added to a flask
containing 200 ml Brucella broth and incubated for an additional
48 h.
Animals, aerosol exposure, sampling, necropsy and tissue
collection. Twenty-four adult rhesus macaques (Macaca mulatta)
were surgically implanted with Data Sciences International TA-D70
temperature and activity telemetry transmitters. Twelve macaques
were assigned to this study and 12 were ‘historical controls’ from a
previous study in which all handling, conditions and time points were
identical. Experimental animals were exposed to Brucella organisms
diluted in normal saline solution whereas historical controls were
exposed to saline solution only. Control animals were necessary to
Abbreviations: BAL, broncho-alveolar lavage; CBC, complete blood
count.
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(body temperature and activity) as well as PCR, i.e. to ensure that the
assay did not result in false-positives or -negatives when used on a
given tissue type. Temperature and activity data were sampled every
15 min from 1 week before exposure until time of euthanasia.
Complete blood counts (CBCs) and blood chemistries were
performed 7, 14 and 30 days before exposure. Swab samples were
taken from the face, conjunctiva, buccal mucosa, pharynx, nares and
external auditory meatus and broncho-alveolar lavage (BAL) was
performed immediately before exposure in order to obtain animal-
matched negative control samples for PCR analysis. Extensive
experience at the US Army Medical Research Institute of Infectious
Diseases indicates that BAL does not affect susceptibility or disease
progression in aerosol-exposed animals.
Experimental animals were exposed to approximately 1 mm mass
median aerodynamic diameter aerosolized particles of B. suis in a
manner that standardizes the number of c.f.u. inhaled. Animals were
anaesthetized in accordance with institute policy. Respiratory minute
volumes were estimated immediately prior to exposure using head-
out plethysmography (Buxco Research Systems). Respiratory minute
volume was assumed to be constant over the exposure period. Each
animal was exposed separately in a well-characterized dynamic
airflow exposure chamber (Dabisch et al., 2010). Small particle
aerosols were generated using 10 ml agent diluted in normal saline in
a 3-jet Collison nebulizer (BGI). The generated aerosol was sampled
using all-glass impingers attached to the exposure chamber. The
contents of the impinger were assayed post-exposure to estimate
the mean agent concentration in the chamber during the exposure.
The estimated inhaled dose was calculated as the product of the
chamber aerosol concentration, the respiratory minute volume and
exposure duration. In order to achieve a targeted dose, the exposure
duration was varied from animal to animal since both the chamber
aerosol concentration and estimated respiratory minute volume are
assumed to be constant throughout the exposure period. Exposure
durations ranged from 5 to 15 min. The aerosol respiratory
deposition fraction was assumed to be 100%. Following aerosol
exposure, the head of each monkey was wiped with a soap solution to
remove deposited aerosol, and monkeys were housed individually
under BSL-3 conditions.
Animal care was provided in accordance with established guidelines
(Committee on Care and Use of Laboratory Animals of the Institute
of Laboratory Animal Resources, National Research Council, 1996).
Three monkeys from each group were euthanized on days 1, 3, 5 and
7 post-exposure. On the day of euthanasia, CBC and blood
chemistries, swab sampling (face, conjunctiva, buccal mucosa,
pharynx, nares and external auditory meatus) and BAL were
performed. During necropsy, urine was sampled by needle puncture
of the exposed urinary bladder, specific organs and tissues were
examined grossly, and representative samples were collected for
histological evaluation. Tissue samples collected for histological
evaluation were from the mandibular lymph node, liver (right caudal
lobe), kidney (left), spleen, heart (ventricle), lung (right cranioventral
lobe), hilar (tracheobronchial) lymph node, mesenteric lymph node,
epididymis/ovarian tube, testis/ovary, prostate/uterus, ileocaecal
junction, large intestine, bone marrow and brain (cerebrum).
The following testing was conducted in order to assess tissue
distribution of Brucella and ability to detect the organism or its
DNA in various samples in order to improve diagnostic methods.
Bacterial culture. For bacterial culture, tissues were ground with a
manual tissue grinder and diluted to a 10% concentration in PBS.
Swabs were immersed in 1 ml PBS. EDTA anti-coagulated blood,
serum, BAL wash fluid and urine were used without further
manipulation. All samples were serially diluted up to 10-fold. Serial
dilutions were plated on Brucella agar and incubated in 5% CO2 at
37 uC in a humid incubator for 3 days. Samples were plated in
triplicate and the three plate reads were averaged to generate the
reported value. Any colony with the phenotypic characteristics of
Brucella was counted as a Brucella organism.
Histopathology. Tissue samples were immersion-fixed in 10%
neutral-buffered formalin and prepared for histopathology. Sections
were embedded in paraffin, sectioned, and cut at 5–6 mm, mounted
on glass slides, and then stained with haematoxylin and eosin in
preparation for examination by light microscopy.
PCR. Swab diluents, BAL wash fluid, 10% suspensions of ground
tissue samples, blood, serum and urine were extracted using the Qiagen
DNA blood kit according to the manufacturer’s instructions. PCR was
performed on a Roche LightCycler 1.5 real-time PCR instrument as
previously described using primers and probes for the Brucella omp2A
gene (Christensen et al., 2006). The forward and reverse primer and
minor groove binder probe sequence for this assay are CCA-
ggCgTACCggTTATCTC, AgACCCTTTTgAggTCTACTCCCTTA and
TggTCgAAggCgCTC,respectively.Thelimit ofdetectionofthisassayis
approximately 30 genome copies. Extracted DNA from Brucella
melitensis strain 16M was used as a sample positive control. Samples
were run in triplicate.
Statistics. Paired t-tests for CBC and chemistry laboratory test values
at day of bleed were compared to baseline values for each day with
stepdown Sidak adjustments for multiple comparisons. Three pre-
bleed values for chemistry and CBC tests were averaged to obtain the
baseline value for each subject.
All tissue bacterial load values were log10 transformed for analysis.
All temperature and activity data were log10 transformed for analysis.
After transformation, variables were better fitted to the assumptions
required for time series analysis. Temperatures and activity levels
from the first 72 h were taken to be baseline values and were
compared to temperatures or activity levels from the 72 h
immediately before euthanasia. Telemetry of subjects euthanized on
a given day (1, 3, 5 and 7) was analysed separately. Data for subjects
euthanized on day 1 could not be made to fit the model due to
insufficient number of time points immediately before euthanasia and
were not analysed in this manner as a result. A time series model for
temperature and activity was developed to examine differences
between baseline temperatures or activity and temperatures or
activity 72 h before euthanasia. The baseline series was used to
identify an Auto-Regressive Integrated Moving Average (ARIMA)
model. ARIMA is necessary to compare telemetry values obtained
with a short lag between measurements, because subsequent values
are influenced by previous values; regression or similar models cannot
be used because independence of errors cannot be assumed. Because
telemetry data were obtained every 15 min, differences were
calculated at lags 1 and 96 in order to convert the raw non-stationary
data to a stationary form that allows for comparison.
For direct assessment of fever spikes, fever was defined as a repeated
measurement of a body temperature greater than or equal to 39.5 uC,
in accordance with the institute animal care standard.
RESULTS AND DISCUSSION
Exposure dose
Actual inhaled dosages of B. suis averaged 5.60610
8 c.f.u.
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various samples
Nasal and/or pharyngeal swabs are common samples used
to diagnose uncomplicated viral and bacterial aetiologies of
febrile respiratory illnesses, whereas BAL may be ordered in
cases with obvious pneumonia. Respiratory illness is a less
common manifestation of naturally acquired brucellosis in
humans; however, in light of the clear signs of bronchiolitis
in the rhesus model under these conditions (see below),
human cases occurring as a result of an intentional aerosol
exposure may present with respiratory signs in addition to
fever and a clinician might take nasal and pharyngeal swabs
and, more rarely, BAL, without considering brucellosis to
be a differential diagnosis. Brucella organisms were
detected by routine culture (see Methods) and Brucella
DNA was detected by real-time PCR of non-invasive
diagnostic samples (pharyngeal and nasal swabs) and in
BAL immediately after exposure and for 7 days after
exposure. This is a novel finding and it is key in that,
although this was a high-dose aerosol exposure not likely to
be replicated in nature, obtaining both positive cultures
and PCR detection from such samples argues for including
PCR for Brucella in the diagnostic algorithm when an
apparent point-source outbreak of respiratory illness
occurs and cannot otherwise be diagnosed.
Brucella was never isolated from or detected by PCR of
blood, serum or urine. Failure to detect Brucella in blood
components or urine correlates well with human clinical
diagnostics experience. Culture and PCR showed a
progression of the pathogen from lung to spleen and liver,
and finally to the bone marrow over the 7 day course of the
experiment (Tables 1 and 2). In human brucellosis, it is
recognized that Brucella quickly disseminates to the
lymphatics as well.
Notably, PCR was positive in the gonads by day 5 in all
cases, in both sexes (though, by chance, the animals
remaining in the experiment by day 5 included only one
male animal). This correlates well with the propensity for
B. suis to localize to the testes in humans. PCR was not well
correlated with gross or histopathology findings in the
mesenteric lymph nodes, but did accord well with tracheo-
bronchial lymph node pathology and became positive in a
progressively larger number of mandibular lymph nodes
throughout the 7 day course of the study. There was also
frequent detection by PCR in the large intestine and kidney
later in the study, perhaps indicating wide-ranging tissue
dissemination. It quickly became impossible to detect
Brucella DNA in buccal swabs, indicating that it does not
remain in the mouth. Surprisingly, PCR was also frequently
positive in face, conjunctival and aural swabs throughout
the 7 day course of the study; however, these would not be
likely diagnostic samples in a human outbreak situation,
and, at least in the case of face and aural swabs, this
probably did not indicate the presence of viable organisms,
but rather may indicate only the presence of pathogen
DNA in the oily or waxy residues of the face or ear canal.
These samples were not cultured.
PCR and culture results matched in all cases for lung, liver
and spleen. Brucella was cultured from one BAL sample on
day 7, and from two pharyngeal swab samples on each of
days 5 and 7, while DNA was not detected by PCR. Brucella
DNA was detected by PCR in bone marrow in one case on
day 5, in the pharyngeal swab in one case on day 1 and in
the nasal swab in one case on day 3 and two cases each on
days 5 and 7, in which culture was not positive. All
diagnosis mis-matches were in cases where relatively lower
amounts of bacteria were recovered or the PCR threshold
crossing value was relatively higher, indicating lower levels
of Brucella or Brucella DNA at the lower limit of detection,
wherein both methods become unreliable.
Overall, these results indicate that a battery of tests on a
maximum number of sample types should be conducted to
optimize the chances of detecting Brucella. However, when
Brucella is not suspected in an outbreak situation, yet no
other diagnostic methodologies yield a diagnosis, screening
for Brucella by PCR may prove rewarding. Based on these
results, neither culture nor PCR can be considered ideal for
diagnosis of individual cases; however, the discrepancies in
no way reduce the validity of including PCR in the
Table 1. Log10 c.f.u. of bacteria (g tissue)
”1 or (ml fluid)
”1 detected from B. suis-infected rhesus macaques
Numbers in parentheses denote the number of animals out of a total of three per time point in which B. suis was detected, if less than three. Blood
and serum were also cultured but no organism was detected from these fluids. Data are reported as mean±standard error of the mean.
Tissue/sample type Day
13 5 7
Lung 3.16±0.86 5.19±0.79 4.66±0.57 5.31±0.49
Liver 0.75±0.16 (2) 1.60±0.15
Spleen 1.85±0.59 (2) 3.32±0.41
Bone marrow 0.98±0.26
Pharyngeal swab 3.91±0.43 4.14±0.35 3.66±0.17 2.84±0.15 (2)
Nasal swab 2.27±0.16 3.93±0.43 (2) 1.85 (1) 5.04 (1)
Broncho-alveolar lavage 5.70±1.84 2.50±0.26 2.25±0.40 1.31±0.01
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normal to either detect Brucella DNA or recover it by
culture in a human being. Therefore, any positive result
would be cause for further investigation. PCR is the ideal
method of the two for screening because it is vastly faster
and largely obviates biosafety problems that result from
Brucella culture.
Telemetry data
The intervention parameter, which distinguished baseline
temperatures from temperatures immediately prior to
euthanasia, was not statistically significant for those
subjects euthanized on day 3 (P50.9861) but was
significant for those subjects euthanized on days 5
(P50.0270) and 7 (P50.0037). Fever spikes were detected
in single monkeys on days 1 and 2 and in three monkeys on
day 3 (Fig. 1). Fever spikes were not noted on any other
days. Fever was never detected in control monkeys.
Although the rhesus model does not allow assessment of
fever-related manifestations of brucellosis that occur in
humans (e.g. night sweats), waxing and waning fever is
consistent with human brucellosis and indicates that the
rhesus macaque is a good model for human brucellosis.
No change in activity levels was detected. No significant
CBC or blood chemistry aberrations were detected. This is
also consistent with human brucellosis because clinical
pathology indicators are indistinct in human brucellosis
(Demirtu ¨rk et al., 2008).
Gross pathology
In terms of gross pathology, from day 1 post-exposure
through day 7, there were varying degrees of enlargement
of the mesenteric, tracheobronchiolar and mandibular
lymph nodes. In all cases there was mild oedema. There
were no significant gross findings in the remaining organs.
On day 1 post-exposure, the most significant gross findings
were enlarged and slightly oedematous mesenteric lymph
nodes (two to three times normal). By day 3, mesenteric
lymph nodes were enlarged by up to five times normal and
remained mildly oedematous. At that time point, the
tracheobronchial lymph nodes were enlarged up to three
times normal and the mandibular lymph nodes were also
slightly enlarged in two of the three monkeys sampled on
that day.
On day 5, the mesenteric lymph nodes were still
oedematous and enlarged, but only up to three times
normal. The tracheobronchial lymph nodes were enlarged
three to four times normal and congested. The mandibular
lymph nodes were slightly enlarged. By day 7, the
Table 2. PCR results from tissues or other samples from B. suis-infected rhesus macaques
Numbers denote the mean threshold crossing point of a triplicate for a given animal (three per time point, except in the case of reproductive
organs, where the number per time point is indicated in parentheses). Brain, blood, serum, urine and small intestine were never positive.
Tissue/sample type Day
135 7
Pharyngeal swab 37.2, 38.0 33.8, 36.7, 36.8 38.0
Nasal swab 25.8, 29.2, 29.3 30.0, 34.6, 36.2 32.9, 34.4, 36.0 34.8, 36.3, 37.6
Face swab 27.7, 27.8, 28.7 32.1, 30.3 30.5, 34.0, 34.4 32.6, 33.7, 34.2
Conjunctival swab 30.0, 30.7, 32.5 31.0, 33.6, 36.4 31.7 33.7, 34.3, 36.1
Buccal mucosal swab 35.5 36.7
Aural swab 29.1, 29.5, 29.8 30.4, 30.9, 32.7 29.6, 31.7, 33.9 33.0, 33.2, 34.4
Heart 37.2 37.5
Kidney 34.2, 36.9, 37.9 38.0
Large intestine 34.1 31.1, 33.5, 34.5 31.9, 34.6
Testes (1) (1) 35.6 (1)
Epididymis (1) (1) 33.0 (1)
Prostate (1) (1) 34.3 (1)
Ovary (2) (2) 36.2, 36.4 (2) 33.7, 35.5, 35.7 (3)
Uterine tube (2) (2) (2) (3)
Uterus (2) (2) (2) (3)
Mesenteric lymph node 36.4, 36.8
Tracheobronchial lymph node 29.2, 32.2, 32.8 24.6, 29.2, 29.7 26.3, 27.0, 27.1 26.8, 29.7, 34.1
Mandibular lymph node 29.6 27.5, 34.1 30.6, 31.8, 33.4
Lung 23.5, 26.7, 35.7 22.3, 24.6, 25.7 23.3, 24.2, 24.9 24.3, 24.7, 27.5
Liver 34.6, 35.5 32.3, 33.8, 34.1
Spleen 32.3, 38.4 30.8, 34.3, 35.3
Bone marrow 35.7 34.2, 35.9, 36.1
Broncho-alveolar lavage 29.0, 31.0, 31.3 32.7, 33.6, 35.1 34.0, 35.6, 36.2 34.9, 36.4
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normal and oedematous. The tracheobronchial lymph
nodes were enlarged up to four times normal and
oedematous. The mandibular lymph nodes were still
slightly enlarged.
Enlarged lymph nodes were occasionally noted in the
controls; however, oedema was not noted. Lung congestion
was noted in two of three exposed monkeys euthanized on
days 1 and 3 after exposure, and in one of three monkeys
euthanized on days 5 and 7 after exposure.
The mesenteric lymph nodes were the first to show any
significant macroscopic changes. By day 3, they were their
largest over the span of 7 days. The tracheobronchial
lymph nodes did not show any significant changes until
day 3 and then reached the maximum noted size by day 7.
These findings were non-specific, and are consistent with
varying degrees of antigenic stimulation that corresponds
to the lymphoid hyperplasia noted histologically (see
below). There was no corresponding pattern of lymph
node enlargement in the controls as was noted in the
exposed animals. There was more oedema of the lymph
nodes in the exposed animals than in the controls. Oedema
is often an early (acute) manifestation of inflammation and
may occur prior to any other grossly detectable indication
of inflammation (Kumar et al., 2005). The lung congestion
noted was likely a terminal event related to the method
of euthanasia. All gross and histological findings were
non-specific and would not be attributable to any specific
agent this early in the course of the disease.
Histology
In terms of histological findings, the lymphoid hyperplasia
and lymph node oedema corresponded with the gross
findings of lymph node enlargement and oedema. There
were no other significant histological findings specifically
attributable to exposure to aerosolized B. suis. On day 3,
there was multifocal bronchiolar epithelial degeneration
and necrosis, with mild lymphohistiocytic and neutrophilic
bronchiolitis and peribronchiolitis with alveolar oedema.
The inflammation worsened by day 5 and the oedema was
more pronounced. By day 7, the inflammation was similar
to that observed on day 5 but the perivascular oedema was
slightly more pronounced. By day 7, two out of three
rhesus macaques showed mild lymphohistiocytic hepatitis.
All tissues were stained with haematoxylin and eosin only
and there was no attempt to visualize Brucella organisms in
tissues. This corresponds with the approach that would be
expected to be taken in diagnosing a biopsy specimen from
an unknown case of acute febrile illness. There is virtually
no information in the literature concerning histological
findings in the lymph nodes of human patients.
Occasionally, brucellosis has manifested as hepatitis, so
there is a slight possibility that a liver biopsy might be a
primary diagnostic sample for brucellosis, but there is
Fig. 1. Temperature trends in four monkeys that showed fever spikes (black, red, yellow and green lines). Lines terminate on
days on which animals were euthanized according to the protocol schedule.
S. L. Yingst and others
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course of infection because hepatic enlargement or changes
notable on ultrasound are not reported to occur early in
the course of exposure (Akritidis et al., 2007). Based on the
limited information available, our data are consistent with
reports of liver histology in human brucellosis, i.e. that
parenchymal necrosis and lymphocytic infiltration are
common. Histological findings in pulmonary brucellosis
cases vary, and the vast majority of information available in
the literature is associated with chronic cases, but our data
are consistent with the limited amount available, i.e. that
inflammation is often lymphohistiocytic and/or neutro-
philic (Theegarten et al., 2008). We did not observe
progression to granulomatous inflammation, presumably
because of the short duration of the study. However, in
fact, the histology findings in our study are meaningful for
their indistinctiveness; that is, in contrast to later stage B.
suis infection, in this model of acute B. suis infection, no
major histological abnormalities were observed. Therefore,
alternative diagnostic methods such as PCR would be
expected to be preferable due to their higher speed and
throughput. In other words, when faced with an unknown,
the diagnostician may use PCR as a screening method.
Conclusions
Taken together, these data indicate that the rhesus
macaque is a good model of human brucellosis. If this is
the case, then an intentional human exposure would not be
associated with any distinctive clinical, haematological or
pathological signs. There would be little basis to suspect
any aetiology, let alone brucellosis. For this reason, a rapid,
reliable screening test is essential. Our data indicate that an
intentional human exposure by aerosol can be detected by
PCR of non-invasive samples, i.e. nasal and/or pharyngeal
swabs. We detected Brucella DNA in nasal swab samples in
all three monkeys sampled at each time point (days 1, 3, 5
and 7 after exposure – with progressively declining
apparent concentration based on the mean PCR threshold
crossing points) and in pharyngeal swabs in two cases on
day 1, three cases on day 3 and one case on day 5. DNA
concentrations were not standardized; all methods were
conducted in a manner similar to that which would be
expected in a clinical diagnostic laboratory, i.e. qualitative.
In an intentional exposure scenario, it is reasonable to
expect a wide range of exposure doses, such that a subset of
individuals would inhale a high dose; the far end of this
spectrum was modelled in this study. Heavily exposed
humans would probably experience upper respiratory
illness and potentially enlarged regional lymph nodes.
Physicians commonly attempt diagnosis of such cases with
nasal and/or pharyngeal swabs, which are submitted for
culture. Culture could also be rewarding in high-dose
exposure cases, but PCR would provide a diagnosis
within hours whereas culture would require days. The
PCR assay used here is highly specific for the Brucella
genus and Brucella is never normal flora for humans, so a
PCR-positive sample would provide a high degree of
confidence that a diagnosis had been made. The primary
importance of these data is to show that adding PCR assays
for selected agents can result in a diagnosis in an otherwise
confusing outbreak situation, in a timely enough fashion
that successful treatment and attribution may be possible.
It would be reasonable in this scenario to empirically treat
symptomatic individuals that may also have been exposed,
but for which no definitive diagnosis could be obtained.
Diagnosis of individuals exposed to a lower dose may still
require invasive methods such as lymph node or bone
marrow biopsy. In this study, neither culturable organism
nor bacterial DNA could be found in blood, urine or any
other non-invasive sample except certain swabs.
In contrast to the study conducted by Mense et al. (2004),
this study shows for the first time that high-dose Brucella
exposure of rhesus macaques can result in rapid illness and
early dissemination to the entire haematopoietic system,
liver and gonads. The diagnostic methods are expected to
be applicable to other pathogenic Brucella species. B.
melitensis, Brucella abortus and B. suis cause the vast
majority of human disease. Brucella canis has been
associated with human disease only in immunosuppressed
patients, and marine mammal Brucella species have been
associated with isolated cases of human disease but
speciation continues to be debated (Aleixo et al., 1999;
Maquart et al., 2008; Whatmore et al., 2008). B. abortus was
once common in the United States and caused hundreds of
cases of human brucellosis annually, before being largely
eradicated toward the end of the last century. B. melitensis
is generally regarded as the most important species because
it is associated with most severe human cases; however, this
is due in part simply to its greater prevalence in key animal
reservoirs. B. suis also causes severe disease in humans, but
B. melitensis causes more obvious, ‘classical’ undulant fever
while B. suis-associated disease is often associated with
abscess formation (Young, 1983). Laboratory-acquired
infection is a common cause of brucellosis and historical
evidence of laboratory exposure and infection indicates
that the infectious dose of Brucella is extremely low. B. suis
was weaponized by the US, former Soviet Union and China
(Hoover & Friedlander, 1997) and this was an important
factor in our decision to model B. suis infection as opposed
to any other species of Brucella. A further reason for
choosing to perform these studies with B. suis as opposed
to B. melitensis or B. abortus is that the main surface
antigen of B. abortus (so-called ‘A’ antigen) and that of B.
melitensis (so-called ‘M’ antigen) are both present in B.
suis. Therefore, B. suis-infected tissues archived during the
course of this study can serve as a test set for future
diagnostic assays specifically designed to detect either
antigen.
ACKNOWLEDGEMENTS
The opinions, interpretations, conclusions and recommendations are
those of the authors and are not necessarily endorsed by the US Army.
A rhesus macaque model of brucellosis
http://jmm.sgmjournals.org 729Work at USAMRIID was funded by DOD grant (Project# 02-4-KK-
032 8.10030_07_RD_B). Research was conducted in compliance with
the Animal Welfare Act and other federal statutes and regulations
relating to animals and experiments involving animals and adheres to
principles stated in the Guide for the Care and Use of Laboratory
Animals, National Research Council, 1996. The facility where this
research was conducted is fully accredited by the Association for
the Assessment and Accreditation of Laboratory Animal Care
International. We thank Dave Dyer for extensive support for aerosol
exposure and telemetry and Diana Fisher for statistical support.
REFERENCES
Akritidis, N., Tzivras, M., Delladetsima, I., Stefanaki, S.,
Moutsopoulos, H. M. & Pappas, G. (2007). The liver in brucellosis.
Clin Gastroenterol Hepatol 5, 1109–1112.
Aleixo, M. J., Ferreira, M. L. & Antunes, F. (1999). Brucellosis. Acta
Med Port 12, 323–330.
Christensen, D. R., Hartman, L. J., Loveless, B. M., Frye, M. S.,
Shipley, M. A., Bridge, D. L., Richards, M. J., Kaplan, R. S., Garrison, J.
& other authors (2006). Detection of biological threat agents by real-
time PCR: comparison of assay performance on the R.A.P.I.D., the
LightCycler, and the Smart Cycler platforms. Clin Chem 52, 141–
145.
Committee on Care and Use of Laboratory Animals of the Institute
of Laboratory Animal Resources, National Research Council
(1996). Guide for the Care and Use of Laboratory Animals. National
Institutes of Health Publication No. 86–23. Washington, DC:
National Institutes of Health.
Dabisch, P. A., Kline, J. L., Lewis, C., Yeager, J. J. & Pitt, M. L. M.
(2010). Characterization of a head-only aerosol exposure chamber for
nonhuman primates. Inhal Toxicol 22, 224–233.
Demirtu ¨rk, N., Demirdal, T., Erben, N., Demir, S., Asci, Z., Kilit, T. P. &
Kartal, E. D. (2008). Brucellosis: a retrospective evaluation of 99 cases
and review of brucellosis treatment. Trop Doct 38, 59–62.
Franco, M. P., Mulder, M., Gilman, R. H. & Smits, H. L. (2007). Human
brucellosis. Lancet Infect Dis 7, 775–786.
Franz, D. R., Jahrling, P. B., McClain, D. J., Hoover, D. L., Byrne, W. R.,
Pavlin, J. A., Christopher, G. W., Cielak, T. J., Friedlander, A. M. &
Eitzen, E. M., Jr (2001). Clinical recognition and management of
patients exposed to biological warfare agents. Clin Lab Med 21, 435–
473.
Hoover, D. L. & Friedlander, A. M. (1997). Brucellosis. In Textbook of
Military Medicine: Medical Aspects of Chemical and Biological Warfare,
pp. 513–521. Edited by F. R. Sidell and others. Washington, DC:
Borden Institute.
Kumar, V., Abbas, K., Fausto, N. (editors) (2005). Robbins and Cotran
Pathologic Basis of Disease, 7th edn, pp. 50–51. Philadelphia, PA:
Elsevier Saunders.
Maquart, M., Fardini, Y., Zygmunt, M. S. & Cloeckaert, A. (2008).
Identification of novel DNA fragments and partial sequence of a
genomic island specific of Brucella pinnipedialis. Vet Microbiol 132,
181–189.
Mense, M. G., Borschel, R. H., Wilhelmsen, C. L., Pitt, M. L. & Hoover,
D. L. (2004). Pathologic changes associated with brucellosis experi-
mentally induced by aerosol exposure in rhesus macaques (Macaca
mulatta). Am J Vet Res 65, 644–652.
Theegarten, D., Albrecht, S., To ¨tsch, M., Teschler, H., Neubauer, H.
& Al Dahouk, S. (2008). Brucellosis of the lung: case report and review
of the literature. Virchows Arch 452, 97–101.
Whatmore, A. M., Dawson, C. E., Groussaud, P., Koylass, M. S., King,
A. C., Shankster, S. J., Sohn, A. H., Probert, W. S. & McDonald, W. L.
(2008). Marine mammal Brucella genotype associated with zoonotic
infection. Emerg Infect Dis 14, 517–518.
Yagupsky, P., Peled, N., Press, J., Abu-Rashid, M. & Abramson, O.
(1997). Rapid detection of Brucella melitensis from blood cultures by a
commercial system. Eur J Clin Microbiol Infect Dis 16, 605–607.
Young, E. J. (1983). Human brucellosis. Rev Infect Dis 5, 821–842.
Young, E. J. (1995). An overview of human brucellosis. Clin Infect Dis
21, 283–289.
S. L. Yingst and others
730 Journal of Medical Microbiology 59